Literature DB >> 29330445

A novel approach for correction of crosstalk effects in pathway analysis and its application in osteoporosis research.

Yu Zhou1,2, Yunlong Gao1,3, Chao Xu1,3, Hui Shen1,3, Qing Tian1,3, Hong-Wen Deng4,5,6.   

Abstract

Osteoporosis is a prevalent bone metabolic disease and peripheral blood monocytes represent a major systemic cell type for bone metabolism. To identify the key dysfunctional pathways in osteoporosis, we performed pathway analyses on microarray data of monocytes from subjects with extremely high/low hip bone mineral density. We first performed a traditional pathway analysis for which different pathways were treated as independent. However, genes overlap among pathways will lead to "crosstalk" phenomenon, which may lead to false positive/negative results. Therefore, we applied correction techniques including a novel approach that considers the correlation among genes to adjust the crosstalk effects in the analysis. In traditional analysis, 10 pathways were found to be significantly associated with BMD variation. After correction for crosstalk effects, three of them remained significant. Moreover, the MAPK signaling pathway, which has been shown to be important for osteoclastogenesis, became significant only after the correction for crosstalk effects. We also identified a new module mainly consisting of genes present in mitochondria to be significant. In summary, we describe a novel method to correct the crosstalk effect in pathway analysis and found five key independent pathways involved in BMD regulation, which may provide a better understanding of biological functional networks in osteoporosis.

Entities:  

Mesh:

Year:  2018        PMID: 29330445      PMCID: PMC5766601          DOI: 10.1038/s41598-018-19196-2

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  34 in total

1.  Analysis and correction of crosstalk effects in pathway analysis.

Authors:  Michele Donato; Zhonghui Xu; Alin Tomoiaga; James G Granneman; Robert G Mackenzie; Riyue Bao; Nandor Gabor Than; Peter H Westfall; Roberto Romero; Sorin Draghici
Journal:  Genome Res       Date:  2013-08-09       Impact factor: 9.043

2.  Expression profile analysis of new candidate genes for the therapy of primary osteoporosis.

Authors:  Y Zhang; N Wang; J Ma; X C Chen; Z Li; W Zhao
Journal:  Eur Rev Med Pharmacol Sci       Date:  2016       Impact factor: 3.507

Review 3.  Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone.

Authors:  A M Parfitt
Journal:  J Cell Biochem       Date:  1994-07       Impact factor: 4.429

4.  Effects of sex hormones on production of interleukin-1 by human peripheral monocytes.

Authors:  M Morishita; M Miyagi; Y Iwamoto
Journal:  J Periodontol       Date:  1999-07       Impact factor: 6.993

5.  Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis.

Authors:  T Hirayama; L Danks; A Sabokbar; N A Athanasou
Journal:  Rheumatology (Oxford)       Date:  2002-11       Impact factor: 7.580

6.  The human osteoclast precursor circulates in the monocyte fraction.

Authors:  Y Fujikawa; J M Quinn; A Sabokbar; J O McGee; N A Athanasou
Journal:  Endocrinology       Date:  1996-09       Impact factor: 4.736

7.  Body composition in premanifest Huntington's disease reveals lower bone density compared to controls.

Authors:  Anna O G Goodman; Roger A Barker
Journal:  PLoS Curr       Date:  2011-02-28

8.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

Authors:  S Hulley; D Grady; T Bush; C Furberg; D Herrington; B Riggs; E Vittinghoff
Journal:  JAMA       Date:  1998-08-19       Impact factor: 56.272

9.  Normal human peripheral blood mononuclear cells mobilized with granulocyte colony-stimulating factor have increased osteoclastogenic potential compared to nonmobilized blood.

Authors:  L E Purton; M Y Lee; B Torok-Storb
Journal:  Blood       Date:  1996-03-01       Impact factor: 22.113

10.  Identification of transcriptional factors and key genes in primary osteoporosis by DNA microarray.

Authors:  Wengui Xie; Lixin Ji; Teng Zhao; Pengfei Gao
Journal:  Med Sci Monit       Date:  2015-05-09
View more
  13 in total

1.  Up-regulated CST5 inhibits bone resorption and activation of osteoclasts in rat models of osteoporosis via suppression of the NF-κB pathway.

Authors:  Fei Wang; Chuanzhu Zhang; Wei Ge; Guoqiang Zhang
Journal:  J Cell Mol Med       Date:  2019-08-11       Impact factor: 5.310

2.  Integrative Analysis of Genomics and Transcriptome Data to Identify Regulation Networks in Female Osteoporosis.

Authors:  Xianzuo Zhang; Kun Chen; Xiaoxuan Chen; Nikolaos Kourkoumelis; Guoyuan Li; Bing Wang; Chen Zhu
Journal:  Front Genet       Date:  2020-11-30       Impact factor: 4.599

3.  Analysis and Validation of Hub Genes in Blood Monocytes of Postmenopausal Osteoporosis Patients.

Authors:  Yi-Xuan Deng; Wen-Ge He; Hai-Jun Cai; Jin-Hai Jiang; Yuan-Yuan Yang; Yan-Rong Dan; Hong-Hong Luo; Yu Du; Liang Chen; Bai-Cheng He
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-13       Impact factor: 5.555

4.  WGCNA Identification of Genes and Pathways Involved in the Pathogenesis of Postmenopausal Osteoporosis.

Authors:  Meng-Lei Hao; Xiao-Qin Zuo; Yong Qiu; Jian Li
Journal:  Int J Gen Med       Date:  2021-11-16

5.  Consensus gene modules related to levels of bone mineral density (BMD) among smokers and nonsmokers.

Authors:  Bingyuan Lin; Zhijun Pan
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

6.  The telomere length landscape of prostate cancer.

Authors:  Julie Livingstone; Yu-Jia Shiah; Takafumi N Yamaguchi; Lawrence E Heisler; Vincent Huang; Robert Lesurf; Tsumugi Gebo; Benjamin Carlin; Stefan Eng; Erik Drysdale; Jeffrey Green; Theodorus van der Kwast; Robert G Bristow; Michael Fraser; Paul C Boutros
Journal:  Nat Commun       Date:  2021-11-25       Impact factor: 14.919

7.  Beta-caryophyllene prevents the defects in trabecular bone caused by Vitamin D deficiency through pathways instated by increased expression of klotho.

Authors:  Wei Dong; Bradley C Postlethwaite; Patricia A Wheller; David Brand; Yan Jiao; Wei Li; Linda K Myers; Weikuan Gu
Journal:  Bone Joint Res       Date:  2022-08       Impact factor: 4.410

8.  Identification of ferroptosis-associated biomarkers for the potential diagnosis and treatment of postmenopausal osteoporosis.

Authors:  Yunxiang Hu; Jun Han; Shengqiang Ding; Sanmao Liu; Hong Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-29       Impact factor: 6.055

9.  The Genetic Base for Peanut Height-Related Traits Revealed by a Meta-Analysis.

Authors:  Juan Wang; Caixia Yan; Dachuan Shi; Xiaobo Zhao; Cuiling Yuan; Quanxi Sun; Yifei Mou; Haoning Chen; Yuan Li; Chunjuan Li; Shihua Shan
Journal:  Plants (Basel)       Date:  2021-05-25

10.  Overexpression of PIK3R1 Promotes Bone Formation by Regulating Osteoblast Differentiation and Osteoclast Formation.

Authors:  Haitao Zhu; Hua Chen; Degang Ding; Shui Wang; Xiaofeng Dai; Yulong Zhu
Journal:  Comput Math Methods Med       Date:  2021-10-14       Impact factor: 2.238

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.